CELLforCURE by SEQENS is a leading EMA-authorized CDMO dedicated to the development and commercial manufacturing of cell and gene therapies (ATMPs). Located near Paris, the company operates a 10,000 m2 site with 3,000 m2 of GMP area featuring 7 independent GMP manufacturing lines, 48 cleanrooms, and an 800 m2 dedicated QC lab. With over 15 years of track record, CELLforCURE has completed 25+ tech transfers, manufactured 600+ autologous CAR-T commercial doses and 10,000+ allogeneic CAR-T clinical vials.
autologous CAR-T manufacturing, allogeneic cell therapy, GMP manufacturing, tech transfer, cell and gene therapy commercial production, quality control
1 site worldwide
No reviews available yet.
No documents available.